Muscarinic antagonists

Details Muscarinic antagonists Muscarinic antagonists

1999-06-28

2000-05-23

Bernhardt, Emily

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

544238, 544360, 544364, 544379, 546187, 546193, 546194, 546212, 546213, 514316, 514318, 514326, A61K 31496, C07D40514, C07D40114, C07D40314, C07D40914

Patent

active

060666366

ABSTRACT:
Heterocyclic derivatives of di-N-substituted piperazine or 1,4 di-substituted piperidine compounds in accordance with formula I (including all isomers, salts and solvates) ##STR1## wherein wherein one of Y and Z is --N-- and the other is --N-- or --CH--;

REFERENCES:
patent: 4895841 (1990-01-01), Sugimoto et al.
patent: 5061704 (1991-10-01), Wierzbicki et al.
patent: 5889006 (1999-03-01), Lowe et al.
Baumgold, et al., European Journal of Pharmacology 251 (1994) 315-317.
Melchiorre, et al., J. Med. Chem, 1993, 36, 3734-3737.
Logemann, et al., Brit. J. Pharmacol (1961) 17, 286-296.
Watson et al, J. Pharmacol. Exp. Ther., 237 (1986), p. 411-418.
Cheng et al, Biochem. Pharmacol., 22 (1973), p. 3099-3108.
Eberlein, et al., Trends in Pharmacol Sci Dec. 1989 p 50-54.
Doods, et al., Life Sciences, vol. 52, pp. 497-503 (1993).
Kamiya et al, Chem. Pharm. Bull., 21 (7) 1510-15 (1973).
Carcellar et al., Chemical Abstracts, vol. 125, No. 275911 (1996).
Kuno et al, Chem. Pharm. Bull. 41 p. 156-162 (1993).
Ward et al, J. Med. Chem. 35, p. 4011-4019 (1992).
Quirion et al., Tips, p 80-84 (1989).

Affiliated with

Also associated with

Rating

Muscarinic antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Muscarinic antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Muscarinic antagonists will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1837260